Does ADALIMUMAB Cause Injection site erythema? 8,563 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 8,563 reports of Injection site erythema have been filed in association with ADALIMUMAB (YUSIMRY). This represents 1.7% of all adverse event reports for ADALIMUMAB.
8,563
Reports of Injection site erythema with ADALIMUMAB
1.7%
of all ADALIMUMAB reports
3
Deaths
457
Hospitalizations
How Dangerous Is Injection site erythema From ADALIMUMAB?
Of the 8,563 reports, 3 (0.0%) resulted in death, 457 (5.3%) required hospitalization, and 11 (0.1%) were considered life-threatening.
Is Injection site erythema Listed in the Official Label?
Yes, Injection site erythema is listed as a known adverse reaction in the official FDA drug label for ADALIMUMAB.
What Other Side Effects Does ADALIMUMAB Cause?
Drug ineffective (71,926)
Pain (37,514)
Arthralgia (35,592)
Rheumatoid arthritis (29,817)
Fatigue (29,420)
Injection site pain (28,679)
Headache (19,891)
Nausea (19,299)
Rash (18,690)
Pain in extremity (18,319)
What Other Drugs Cause Injection site erythema?
ETANERCEPT (17,736)
DUPILUMAB (8,818)
TIRZEPATIDE (3,844)
TERIPARATIDE (3,453)
GLATIRAMER (2,560)
IXEKIZUMAB (2,144)
ENBREL (1,879)
EVOLOCUMAB (1,754)
HUMIRA (1,654)
DULAGLUTIDE (1,538)
Which ADALIMUMAB Alternatives Have Lower Injection site erythema Risk?
ADALIMUMAB vs ADALIMUMAB-AACF
ADALIMUMAB vs ADALIMUMAB-AATY
ADALIMUMAB vs ADALIMUMAB-ADAZ
ADALIMUMAB vs ADALIMUMAB-ADBM
ADALIMUMAB vs ADALIMUMAB-AFZB